You are here: Industry Insights > COVID-19

News List

Orion Biotechnology Receives Funding to Test OB-002 for COVID-19 americanpharmaceuticalreview
August 11, 2020
Orion Biotechnology Canada announced it is receiving advisory services and conditional funding from the National Research Council Industrial Research Assistance Program (NRC IRAP), to support the development of Orion’s lead compound, OB-002 ...
Pfizer signs multi-year deal to manufacture Gilead’s remdesivir pharmaceutical-technology
August 11, 2020
Pfizer has entered into a multi-year agreement to manufacture and supply Gilead Science’s experimental antiviral drug remdesivir, for the treatment of Covid-19 patients.
GigaGen develops new class of drugs to treat Covid-19 pharmaceutical-technology
August 11, 2020
US-based biotechnology company GigaGen has developed a new class of drugs, called recombinant hyperimmunes, to potentially treat patients with Covid-19.
U.S. Govt. Selects Grand River Aseptic Manufacturing to Help Combat COVID-19 contractpharma
August 11, 2020
HHS and Dept. of Defense call upon the U.S.-based CDMO to expand domestic fill/finish capacity under Operation Warp Speed.
IIT Mandi team compares disordered proteins in COVID-19 virus through computational studies expresspharma
August 11, 2020
Understanding the structure and functions of intrinsically disordered proteins (IDPs), and intrinsically disordered protein regions (IDPR) in COVD-19 can help in finding ways to mitigate the effects of the infection, say researchers.
Neutrolis Develops Treatment Targeting NETs for Patients with Severe COVID-19 americanpharmaceuticalreview
August 10, 2020
Neutrolis announced the development of NTR-441, a first-in-class DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear neutrophil extracellular traps (NETs) for severe cases of COVID-19.
RLF-100 Trial Shows Rapid Recovery from COVID-19 Respiratory Failure americanpharmaceuticalreview
August 10, 2020
NeuroRx and Relief Therapeutics announced that RLF-100 (aviptadil) showed rapid recovery from respiratory failure in the most critically ill patients with COVID-19.
FDA Authorizes First Tests that Estimate Antibodies from Past SARS-CoV-2 Infection americanpharmaceuticalreview
August 10, 2020
The U.S. Food and Drug Administration (FDA) authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in the individual’s blood.
Prices of remdesivir and favipiravir being monitored in India, says report europeanpharmaceuticalreview
August 10, 2020
Regulatory bodies in India are tracking the cost of remdesivir and favipiravir amid the COVID-19 pandemic but should consider price caps, a report has suggested.
Caprion-HistoGeneX and Viroclinics-DDL announce partnership expresspharma
August 10, 2020
The collaboration will offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development.